Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
16.70
1.60 (10.60%)
At close: Aug 14, 2025, 3:59 PM
16.60
-0.60%
Pre-market: Aug 15, 2025, 08:49 AM EDT

Beta Bionics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-54.76M -44.1M -64.75M
Depreciation & Amortization
2.28M 2.09M 2.1M
Stock-Based Compensation
6.38M 5.66M 6.1M
Other Working Capital
5.39M -682K -2.53M
Other Non-Cash Items
9.96M 10.27M -1.12M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-12.15M -6.36M -2.53M
Operating Cash Flow
-48.27M -32.45M -60.21M
Capital Expenditures
-3.4M -402K -772K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-72.13M n/a n/a
Sales Maturities Of Investments
72M n/a n/a
Other Investing Acitivies
50K -69.29M 3K
Investing Cash Flow
-3.48M -69.69M -769K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 101.03M 56.78M
Financial Cash Flow
55.62M 101.03M 56.78M
Net Cash Flow
3.87M -1.11M 27.77M
Free Cash Flow
-51.67M -32.85M -60.98M